A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320 von Townsend, W, Johnson, RJ, Pottinger, BT, Counsell, N, Smith, P, Chadwick, H, Evans, K, Wickham, C, Rudin, CE

Volltext bestellen